carbapenems has been researched along with cefotaxime in 31 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (cefotaxime) | Trials (cefotaxime) | Recent Studies (post-2010) (cefotaxime) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 5,747 | 727 | 790 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.68) | 18.7374 |
| 1990's | 11 (35.48) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 6 (19.35) | 2.80 |
| Authors | Studies |
|---|---|
| Goonetilleke, UR; Jones, DV; Murgatroyd, LB; Topham, JC; Wright, J | 1 |
| Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
| Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
| Allen, S; Barry, A; Fuchs, P; McLaughlin, J; Pfaller, M; Sewell, D | 1 |
| Wilson, SE | 1 |
| Dagan, R; Klugman, KP | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Inoue, E; Mitsuhashi, S | 1 |
| Baker, LW; Hoogkamp-Korstanjep, JA; Huizinga, WK; Karran, SJ; Pezet, DM; Valleur, P; Warren, BL | 1 |
| Chmelik, V; Featherstone, A; Pfausler, B; Schmutzhard, E; Vukmirovits, G; Williams, KJ | 1 |
| Schuler, D | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Manzor, O; Pawlak, J; Saravolatz, L | 1 |
| Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM | 1 |
| Amir, J; Harel, L; Straussberg, R | 1 |
| Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY | 1 |
| Majiduddin, FK; Palzkill, T | 1 |
| Abraham, OC; Brahmadathan, KN; Jagannati, M; John, G; Kaul, S; Pitchamuthu, K; Sudarsanam, TD | 1 |
| Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M | 1 |
| Eb, F; Guillon, H; Mammeri, H; Nordmann, P | 1 |
| Chiu, SK; Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL; Yeh, KM | 1 |
| Boyanova, L; Kaneva, R; Markovska, R; Mitev, V; Mitov, I; Pencheva, D; Stankova, P; Stoeva, T | 1 |
| Aracil, B; Bautista, V; Campos, J; Esteban-Cantos, A; Fernández-Romero, S; Grundmann, H; Lara, N; Navarro, F; Ortega, A; Oteo, J; Pérez-Vázquez, M; Saez, D | 1 |
| Bonomo, RA; Harper, TM; June, CM; Leonard, DA; Powers, RA; Taracila, MA | 1 |
| Hu, L; Palzkill, T; Prasad, BVV; Sankaran, B; Sun, Z | 1 |
| Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
| Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
| Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y | 1 |
| Ho, HC; Huang, C; Li, W; Liu, C; Shi, L; Xia, H; Yang, L; Yang, X; Zeng, Y; Zhang, W | 1 |
| Acman, M; Chiu, CH; Hamawandi, A; Lindsay, JA; Readman, JB; Sharland, M; Standing, JF | 1 |
| Bali, K; Bányai, K; Kardos, G; Kaszab, E; Khayer, B; Koleszár, B; Laczkó, L; Lovas-Kiss, Á; Nagy, JB; Róka, E; Tóth, Á; Ungvári, E; Vargha, M | 1 |
2 review(s) available for carbapenems and cefotaxime
| Article | Year |
|---|---|
Carbapenems: monotherapy in intra-abdominal sepsis.
Topics: Adult; Bacterial Infections; Carbapenems; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Peritonitis; Prospective Studies; Randomized Controlled Trials as Topic | 1995 |
Carbapenem treatment of meningitis.
Topics: Animals; Brain; Carbapenems; Cefotaxime; Cerebrospinal Fluid; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Meningitis, Bacterial; Rabbits | 1995 |
3 trial(s) available for carbapenems and cefotaxime
| Article | Year |
|---|---|
Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cefotaxime; Drug Therapy, Combination; Drug Tolerance; Humans; Meropenem; Metronidazole; Middle Aged; Thienamycins; Treatment Outcome | 1995 |
A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.
Topics: Adult; Carbapenems; Cefotaxime; Ceftriaxone; Humans; Meningitis, Bacterial; Meropenem; Thienamycins; Treatment Outcome | 1995 |
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins | 1995 |
26 other study(ies) available for carbapenems and cefotaxime
| Article | Year |
|---|---|
Safety evaluation of meropenem in animals: studies on the kidney.
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Carbapenems; Cefotaxime; Ceftazidime; Cephaloridine; Female; Kidney Diseases; Macaca fascicularis; Male; Meropenem; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Thienamycins | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; United States | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefaclor; Cefixime; Cefmenoxime; Cefotaxime; Drug Stability; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Microbial Sensitivity Tests | 1994 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Glycopeptides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1999 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden | 1999 |
Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage.
Topics: Carbapenems; Cefotaxime; Cephalosporins; Citrobacter; Combined Modality Therapy; Drainage; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Meningitis, Bacterial; Prognosis; Treatment Outcome | 2001 |
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan | 2005 |
Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Binding Sites; Carbapenems; Cefotaxime; Codon; Escherichia coli; Imipenem; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Penicillins; Substrate Specificity | 2005 |
One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India.
Topics: Carbapenems; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Intensive Care Units; Microbial Sensitivity Tests | 2007 |
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2009 |
Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Cephalosporinase; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Imipenem; Kinetics; Microbial Sensitivity Tests; Plasmids | 2010 |
National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefotaxime; Cefoxitin; Ceftazidime; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2013 |
Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Bulgaria; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefotaxime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2017 |
The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Drug Resistance, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2017 |
Multiple substitutions lead to increased loop flexibility and expanded specificity in
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cloning, Molecular; Crystallography, X-Ray; Doripenem; Escherichia coli; Gene Expression; Genetic Vectors; Imipenem; Kinetics; Models, Molecular; Mutation; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity | 2018 |
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.
Topics: Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cephalosporins; Codon; Drug Resistance, Bacterial; Escherichia coli; High-Throughput Nucleotide Sequencing; Imipenem; Mutation; Penicillins | 2018 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Estimating the effect of increasing ambient temperature on antimicrobial resistance in China: A nationwide ecological study with the difference-in-differences approach.
Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Quinolones; Temperature | 2023 |
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Prevalence; Sulbactam | 2023 |
Carbapenem-resistant Escherichia coli in Black-headed gulls, the Danube, and human clinical samples: A One Health comparison of contemporary isolates.
Topics: Animals; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefotaxime; Charadriiformes; Escherichia coli; Humans; One Health; Water | 2023 |